NTBLQ — Notable Labs Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$3.79m
- $0.31m
US STOCKS-Wall St ends sharply lower amid Trump's tirade against Fed's Powell
US STOCKS-Wall St tumbles as Trump ramps up tirade against Fed's Powell
Brief: Notable Labs Says Co, Units Filed Voluntary Petition Under Provisions Of Chapter 7 Of Title 11 Of US Bankruptcy Code
Brief: Notable Labs Approved A Streamlined Operating Plan Which Includes Exploring Strategic Alternatives
Notable Labs Ltd reports results for the quarter ended in June - Earnings Summary
Notable Labs Ltd expected to post a loss of 43 cents a share - Earnings Preview
Brief: Notable Labs Ltd Files For Offering Up To 19.7 Million Ordinary Shares And Warrants To Purchase Up To 19.7 Million Of Ordinary Shares
Notable Labs Ltd expected to post a loss of 39 cents a share - Earnings Preview
Israeli ADRs up on hopes of de-escalation in Israel-Iran tensions
Notable Labs Ltd reports results for the quarter ended in December - Earnings Summary
Brief: Notable Labs Presents The Design Plan For The PPMP-Enabled Phase 2 Trial With Volasertib For Relapsed/Refractory AML At AACR 2024
Notable Labs Ltd expected to post a loss of 43 cents a share - Earnings Preview
Brief: Notable Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment
Brief: Notable Labs Says Co Got Notification From Nasdaq That Co Has Demonstrated Compliance With Nasdaq's Initial Listing Requirements
U.S. STOCKS ON THE MOVE-DXC Technology, Nvidia, Lisata Therapeutics
US-listed healthcare stocks fall amid Middle East conflict
US-listed healthcare firms down amid Middle East conflict
US-listed shares of Israeli firms slide following Hamas attack
Brief: Vascular Biogenics - Following Execution Of Term Sheet With Wellbeing Group On June 30, Parties Negotiated A Definitive Asset Purchase Agreement